Anticholinergic medications for reducing drooling in children with developmental disability.
Susan M ReidChristine WestburyAngela T GuzysDinah Susan ReddihoughPublished in: Developmental medicine and child neurology (2019)
In drooling, glycopyrrolate produced the greatest improvement with fewer side effects compared with benzhexol and scopolamine. Poor head control and poor oromotor function were associated with poor response. Medication side effects were common and often led to treatment discontinuation. Behavioural issues instigated cessation of benzhexol more often in males than females.